Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
tetrapeptide aldehyde proteasome inhibitor (NEOSH101)
DRUG
2 trials
Sponsors
Neosil, Inc.
Conditions
Androgenetic Alopecia
Phase 2
Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss
Completed
NCT00418730
Neosil, Inc.
Androgenetic Alopecia
Start: 2007-01-31
End: 2008-04-30
Updated: 2008-05-20
Dose-Ranging Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss
NCT00471510
Neosil, Inc.
Androgenetic Alopecia
Start: 2007-05-31
Updated: 2008-05-20